Rezolute, Inc. (RZLT) Financials
RZLT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 102.2 million | 10.4 million |
2023-09-30 | 113.0 million | 9.4 million |
2023-06-30 | 123.7 million | 7.5 million |
2023-03-31 | 134.2 million | 6.9 million |
RZLT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -13.0 million | 1.8 million |
2023-09-30 | -10.6 million | 1.8 million |
2023-06-30 | -11.2 million | 1.8 million |
2023-03-31 | -18.0 million | 1.9 million |
RZLT Net Income
No data available :(
RZLT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 92.6 million | - | 2.5 million |
2023-09-30 | 98.7 million | - | 2.3 million |
2023-06-30 | 101.9 million | - | 2.5 million |
2023-03-31 | 103.1 million | 447000 | 2.4 million |
RZLT Shares Outstanding
RZLT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 12.0 million | 3.2 million | 10000 |
2023-09-30 | - | 12.2 million | 3.7 million | - |
2023-06-30 | 153000 | 10.9 million | 3.3 million | - |
2023-03-31 | - | 14.2 million | 2.9 million | - |
RZLT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 10000 |
2023-09-30 | - | 10000 |
2023-06-30 | - | 128000 |
2023-03-31 | - | 132000 |
RZLT
Price: $3.31
52 week price:
Earnings Per Share: -1.10 USD
P/E Ratio: -0.96
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23600
Market Capitalization: 93.5 million